Figure 3

Survival prediction using a 192-gene signature in two validation datasets. High-risk group defined by a 192 gene set had a significantly shorter overall survival time than low-risk group in GSE8401 (A), GSE19234 (B), and metastatic tumor subgroup of GSE8401 (C), but not in primary tumor subgroup of GSE8401 (D). (By Kaplan-Meier curve method and log-rank statistics based on 100 permutations).